Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dynamics of circulating micro RNA s as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer

11 Aug 2018

Abstract excerpt

BACKGROUND: Circulating microRNAs (miRNAs) have been indicated as predictive biomarkers in breast cancer. We aimed to explore the association of plasma miRNA dynamics with response to neoadjuvant chemotherapy (NCT) and disclose early markers for predicting sensitivity. METHODS: One hundred and nine patients with operable or locally advanced breast cancer, who participated in a prospective clinical trial and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Cancer Cells and Metastasis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30099860
DOI: 10.1002/cam4.1723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Dynamics of circulating micro RNA s as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancerPMID 30099860Read ↗

Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancerSemantic proximity Read ↗

Using Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer is a Cutting-Edge Application of MicroRNA Profiling TechnologySemantic proximity Read ↗

Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patientsSemantic proximity Read ↗

Expression and prognostic value of hsa-miR-206 in non-triple-negative breast cancerSemantic proximity Read ↗

Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in ResistanceSemantic proximity Read ↗

Selected Micro RNAs Regulate Drug Resistance Genes in Breast Cancer.Semantic proximity Read ↗

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOSemantic proximity Read ↗

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal WomenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.